Clinical trials - Press Releases

Date	Title	Company
13-Dec-2019	All haemophilia A patients in Republic of Ireland get continued access to Sobi’s extended half-life factor replacement therapy	Sobi
13-Dec-2019	Emergex Completes First Step in the Development of a Vaccine Candidate Against Intracellular Bacterium and Bioterrorist Agent Francisella Tularensis	Emergex Vaccines Holding Limited
13-Dec-2019	NICE AND THE SMC HAVE PUBLISHED RECOMMENDATIONS ON SHIONOGI’S MULPLEO® (LUSUTROMBOPAG), APPROVING ITS USE FOR THE TREATMENT OF SEVERE THROMBOCYTOPENIA IN ADULT PATIENTS WITH CHRONIC LIVER DISEASE UNDERGOING INVASIVE PROCEDURES	Shionogi & Co., Ltd
13-Dec-2019	Almirall and Iktos announce research collaboration in Artificial Intelligence for new drug design	Almirall, S.A. (ALM)
13-Dec-2019	Moberg Pharma comments on the results of the North American Phase 3 study with MOB-015	Moberg Pharma AB
13-Dec-2019	Nordic Nanovector provides update on LYMRIT 37-05 Phase 1 DLBCL trial	Nordic Nanovector ASA
13-Dec-2019	PureTech Affiliate Akili Announces AKL-T03 Achieved Primary Endpoint, Improving Cognitive Impairments in Major Depressive Disorder Trial	PureTech Health plc
13-Dec-2019	Transgene Reports on the Combination Trial of TG4010, Chemotherapy and Nivolumab in Non-Small Cell Lung Cancer	Transgene
13-Dec-2019	ViiV Healthcare files submissions to the FDA and EMA for the first-ever dispersible formulation of dolutegravir (DTG) for children living with HIV	ViiV Healthcare
13-Dec-2019	Hansa Biopharma has agreed with the FDA on a regulatory path forward for imlifidase in kidney transplantation of highly sensitized patients in the U.S.	Hansa Biopharma
13-Dec-2019	Medication storage and dosage advice for parents	Valley Northern Limited
12-Dec-2019	Vertex Announces European Commission Approval for KALYDECO® (ivacaftor) in Infants With Cystic Fibrosis Ages 6 Months to Less Than 12 Months With Certain Mutations in the CFTR Gene	Vertex Pharmaceuticals
12-Dec-2019	CarThera signs a strategic collaboration with Lantheus for its SonoCloud device microbubbles	CarThera
12-Dec-2019	Syndivia Raises €1M Investment to Advance Its Tumour Microenvironment Drug Delivery Platform	Syndivia
12-Dec-2019	Sanofi and Regeneron announce intent to restructure Antibody collaboration for Kevzara® (sarilumab) and Praluent® (alirocumab)	Sanofi
12-Dec-2019	Emergex Successfully Completes Preclinical Testing of its Lead ‘Set-Point’ Vaccine Candidate for Dengue Fever and Other Flaviviruses	Emergex Vaccines Holding Limited
12-Dec-2019	Darzalex®▼ (daratumumab) Shows Overall Survival Benefit and Continued Improvement in Progression-Free Survival in Patients with Newly Diagnosed Multiple Myeloma Who are Ineligible for Transplant	the Janssen Pharmaceutical Companies of Johnson & Johnson
12-Dec-2019	Darzalex®▼ (daratumumab) Regimen Shows Significant Increase in Progression-Free Survival in Treatment of Patients with Relapsed/Refractory Multiple Myeloma	The Janssen Pharmaceutical Companies of Johnson & Johnson
12-Dec-2019	KITE, A GILEAD COMPANY, PRESENTS RESULTS FROM PIVOTAL ZUMA-2 TRIAL IN RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA	Kite, a Gilead Company
12-Dec-2019	PureTech Affiliate Vedanta Biosciences Announces Initiation of First-in-Patient Study of Immuno-Oncology Candidate VE800 In Combination with Bristol-Myers Squibb's Opdivo® (Nivolumab)	Vedanta Biosciences